According to Wu, Numerai announced the completion of a $30 million Series C funding round, led by several university endowment funds, with a post-money valuation of $500 million, approximately five times the valuation in 2023. Existing investors such as Union Square Ventures, Shine Capital, and Paul Tudor Jones also participated in the round. The company recently received up to $500 million in capacity support from JPMorgan Chase and repurchased $1 million in NMR from the open market.

NMR-1.09%
View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin